Elanco Animal Health Inc is a leading innovator in the animal health sector, focusing on products for both pets and farm animals. With a rich history since 1954, Elanco provides a wide range of ...

Stifel lowered the firm’s price target on Elanco (ELAN) to $18 from $20 and keeps a Buy rating on the shares. The firm’s thesis remains that ...

Elanco Animal Health is making progress on debt repayment, new product approvals, and launches. Learn why ELAN stock is a Buy ...

Elanco Animal Health Inc (ELAN) stock saw a decline, ending the day at $11.43 which represents a decrease of $-0.12 or -1.04% from the prior close of $11.55. The stock opened at $11.4 and touched a ...

Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to perform badly. Zooming in on an example, the Elanco Animal Health Incorporated ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Elanco Animal Health (ELAN – Research Report), with a price ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.49% of ...

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease ...

Elanco Animal Health Inc. (NYSE:ELAN), a leading player in the animal health industry with a market capitalization of $5.95 billion, has been navigating a complex landscape of product launches, ...